Jason Blue-Smith
1 ta ish
Imperial Cancer Research Fund Cancer and Immunogenetics Laboratory and Wellcome Trust Centre for Human Genetics, University of Oxford, Headington OX3 9DS, United Kingdom; Institute of Immunology, Academy of Sciences, Tashkent, Uzbekistan; Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305; Department of Medical Genetics, Archangelsk State Medical Academy, Archangelsk, Russia; Department of Human Genetics, School of Public Health, University of Texas, Houston, TX